Sientra Big Money Sentiment Up in 2018 Q2 touching 3.75

Sientra, Inc. (NASDAQ:SIEN) Corporate Logo

Positions for Sientra (NASDAQ:SIEN)

“Big money sentiment for Sientra (NASDAQ:SIEN) in 2018 Q2 increased to 3.75, revealed SEC filings. That’s up 2.47, from 2018Q1’s 1.28. 75 funds increased or opened new holdings, while 20 cut down and sold their stakes in Sientra so the sentiment is more positive. Funds own 48.35 million shares, up from 15.33 million shares in 2018Q1. Funds holding Sientra in top 10 was flat from 3 to 3 for the same number . In total 9 funds closed positions, 11 reduced and 36 increased. Also 39 funds bought new Sientra stakes.

Biggest Sientra Shareholders

Abingworth Llp owns 2.48 million shares in Sientra as of 2018 Q2. As of 2018 Q2, 2.73 million shares of Sientra are owned by Clarus Ventures Llc. Pura Vida Investments Llc reported 183,900 shares. Millrace Asset Group Inc. revealed 94,467 shares position in Sientra. The California-based fund Quantum Capital Management looks positive on Sientra, possessing 116,969 shares.

Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products to plastic surgeons in the United States.The firm is worth $492.77 million. The firm offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; and breast tissue expanders.Currently it has negative earnings. It also provides body contouring products; facial and nasal implants; scar management products under the bioCorneum and Silishield brand names; saline-filled breast implant sizers to identify the correct style and size of implants; and non-breast tissue expanders for expanding tissue and skin surface area for burn care and other reconstructive use.

Ticker’s shares touched $17.23 during the last trading session after 4.28% change.Sientra, Inc. has 395,889 shares volume, 14.36% up from normal. SIEN is uptrending and has moved 103.18% since December 8, 2017. The stock outperformed the S&P 500 by 87.56%.

Earnings report for Sientra, Inc. (NASDAQ:SIEN) is expected on March, 12., according to Faxor. Analysts have expectation on stock’s EPS of $-0.68. That’s up 26.09 % from last year’s $-0.92 EPS. -5.56 % EPS growth is what Wall Street’s predicts after $-0.72 reported EPS last quarter.

Clarus Ventures Ltd Liability Company, a Massachusetts-based fund reported 2.73M shs. Rhumbline Advisers reported 0% stake. G2 Prtn Mgmt Limited Liability Company invested in 0.2% or 30,381 shs. Polar Capital Llp holds 0.07% of its capital in Sientra, Inc. (NASDAQ:SIEN) for 565,968 shs. First Manhattan Company invested in 0% or 1,200 shs. Pura Vida Invests reported 183,900 shs or 3.04% of all its holdings. Waddell Reed Fincl Inc reported 770,592 shs. Metropolitan Life Ins Company Ny owns 0% invested in Sientra, Inc. (NASDAQ:SIEN) for 8,191 shs. Art Advsrs Ltd Limited Liability Company reported 36,978 shs stake. Tiaa Cref Inv Llc invested in 0% or 44,937 shs. Legal General Group Inc Public Lc holds 3,461 shs or 0% of its capital. Aqr Capital Limited Liability Corp owns 13,670 shs. Abingworth Ltd Liability Partnership holds 27.6% or 2.48 million shs in its capital. Mutual Of America Llc invested in 0.02% or 61,429 shs. Thompson Davis & owns 2,125 shs.

Sientra, Inc. registered $1.98 million net activity with 0 insider purchases and 2 insider sales since August 31, 2018. Haines Timothy had sold 89,651 shs worth $1.93M on Tuesday, November 6.

Sientra, Inc. (NASDAQ:SIEN) Ratings Coverage

Total analysts of 2 have positions in Sientra (NASDAQ:SIEN) as follows: 2 rated it a “Buy”, 0 with “Sell” and 0 with “Hold”. The positive are 100%. Since August 8, 2018 according to StockzIntelligence Inc Sientra has 2 analyst reports. On Wednesday, August 8 the stock of Sientra, Inc. (NASDAQ:SIEN) has “Buy” rating given by Stifel Nicolaus.

For more Sientra, Inc. (NASDAQ:SIEN) news announced recently go to: Nasdaq.com, Seekingalpha.com, Globenewswire.com, Globenewswire.com or Seekingalpha.com. The titles are as follows: “New Research Coverage Highlights Phibro Animal Health, RadNet, Amphastar Pharmaceuticals, FibroGen, Sientra, and Flexion Therapeutics — Consolidated Revenues, Company Growth, and Expectations for 2018 – Nasdaq” announced on November 27, 2018, “SEC goes after ex Sientra chief after 2015 stock plunge – Seeking Alpha” on September 19, 2018, “Sientra Reports Third Quarter 2018 Financial Results Nasdaq:SIEN – GlobeNewswire” with a publish date: November 06, 2018, “Sientra® to Release Third Quarter 2018 Financial Results on November 6, 2018 – GlobeNewswire” and the last “Sientra, Inc. (SIEN) CEO Jeffrey Nugent on Q3 2018 Results – Earnings Call Transcript – Seeking Alpha” with publication date: November 11, 2018.

Sientra, Inc. (NASDAQ:SIEN) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.